Video Interview with Massimo Radaelli
John E. Kaye
News & Features
- Published
- Videos
Noventia Pharma is a speciality pharmaceutical Company based in Milano, Italy. Founded in 2009 and with operations in Southern Europe, Noventia’s focus is the research, development, and marketing of Orphan Drugs.
Massimo Radaelli is the Founder, President and CEO of Noventia Pharma, and also the CEO and Board Member of Napo Therapeutics. Both companies have Rare Diseases as their primary focus.
TOP STORIES
-
Scotland’s £19bn food and drink industry faces ‘cliff edge’ as costs squeeze businesses -
Lidl owner plans €5.6bn data centre as Germany pushes digital independence -
AI could make it easier for citizens to have their say, study finds
-
Hidden workplace chemical risks come under spotlight as experts turn to skin exposure
-
Cyber attack hits Manchester, Stansted and East Midlands airports as customer data stolen
-
New global map reveals 800 businesses trying to cut plastic waste
-
LEGO sales soar 22% amid World Cup, F1 and Star Wars push
-
Japan switches on its first full-stack neutral-atom quantum computer
-
Britons flock to Greece as tourist numbers jump 15%
-
Sudan’s children get $22m education lifeline ahead of Geneva funding conference
-
Robot beats Usain Bolt’s 100m record at Beijing games
-
Royal Mail posts another target miss
-
New AI master’s aims to turn non-tech graduates into business leaders
-
New direct flights from Paris and Athens open easier route to Alaska
-
Robots that work, play and even tackle the laundry go on show in Beijing
-
Six young sea eagles released on Exmoor after 200-year absence
-
More than half of US travellers now use AI to plan holidays
-
Could wild swimming and camping help reverse Britain’s outdoor play decline?
-
Israeli genomics firm opens easier route to AI system for NHS labs
-
European investors can now trade thousands of US stocks through Kraken
-
Healthcare AI plans hampered by spreadsheets and legacy systems
-
Women form tighter workplace friendships than men, study finds
-
Children now nearly 11 before being allowed to play outside alone
-
Ex-Lenovo executive Sabine Hammer to lead Infinigate’s DACH business
-
Ferrari’s first electric car sells for record US$40m
Video Interview with Massimo Radaelli
John E. Kaye
News & Features
- Published
- Videos
Noventia Pharma is a speciality pharmaceutical Company based in Milano, Italy. Founded in 2009 and with operations in Southern Europe, Noventia’s focus is the research, development, and marketing of Orphan Drugs.
Massimo Radaelli is the Founder, President and CEO of Noventia Pharma, and also the CEO and Board Member of Napo Therapeutics. Both companies have Rare Diseases as their primary focus.
TOP STORIES
-
Scotland’s £19bn food and drink industry faces ‘cliff edge’ as costs squeeze businesses
-
Lidl owner plans €5.6bn data centre as Germany pushes digital independence
-
AI could make it easier for citizens to have their say, study finds
-
Hidden workplace chemical risks come under spotlight as experts turn to skin exposure
-
Cyber attack hits Manchester, Stansted and East Midlands airports as customer data stolen
-
New global map reveals 800 businesses trying to cut plastic waste
-
LEGO sales soar 22% amid World Cup, F1 and Star Wars push
-
Japan switches on its first full-stack neutral-atom quantum computer
-
Britons flock to Greece as tourist numbers jump 15%
-
Sudan’s children get $22m education lifeline ahead of Geneva funding conference
-
Robot beats Usain Bolt’s 100m record at Beijing games
-
Royal Mail posts another target miss
-
New AI master’s aims to turn non-tech graduates into business leaders
-
New direct flights from Paris and Athens open easier route to Alaska
-
Robots that work, play and even tackle the laundry go on show in Beijing
-
Six young sea eagles released on Exmoor after 200-year absence
-
More than half of US travellers now use AI to plan holidays
-
Could wild swimming and camping help reverse Britain’s outdoor play decline?
-
Israeli genomics firm opens easier route to AI system for NHS labs
-
European investors can now trade thousands of US stocks through Kraken
-
Healthcare AI plans hampered by spreadsheets and legacy systems
-
Women form tighter workplace friendships than men, study finds
-
Children now nearly 11 before being allowed to play outside alone
-
Ex-Lenovo executive Sabine Hammer to lead Infinigate’s DACH business
-
Ferrari’s first electric car sells for record US$40m
